Cologuard vs Colonoscopy: Which Is Better?

"Compare Cologuard vs. colonoscopy, including accuracy, cost, screening intervals, benefits, and what happens after a positive result."

Illustration. A doctor explains cancer examination and treatment to a patient at a hospital.

Both can be used to screen adults at average risk, but they work in fundamentally different ways.

Cologuard looks for signs associated with colorectal cancer and precancerous lesions in a stool sample. Colonoscopy directly examines the inside of the colon and can remove many polyps during the same procedure.

Neither test is automatically the right choice for everyone.

For average-risk adults, the American Cancer Society recommends starting colorectal cancer screening at age 45. Its 2026 guidance emphasizes offering multiple screening options because the most effective screening strategy is one that a person actually completes.

The decision between Cologuard and colonoscopy can depend on:

• age;

• colorectal cancer risk;

• family history;

• previous polyps;

• medical history;

• willingness to undergo bowel preparation;

• preference for an at-home test or procedure;

• insurance coverage;

• and willingness to undergo a colonoscopy if a stool test is positive.

Medical information: This article is for educational purposes only and does not replace medical advice. Screening recommendations can differ for people with symptoms, previous colorectal cancer or polyps, inflammatory bowel disease, inherited cancer syndromes, or significant family history.

Cologuard vs Colonoscopy: The Short Answer

If you are an average-risk adult age 45 or older, both Cologuard and colonoscopy can be legitimate colorectal cancer screening options.

But they are not equivalent tests.

The key difference is simple:

Cologuard is a screening test that can lead to colonoscopy. Colonoscopy is both a screening examination and a procedure that can diagnose and treat certain findings during the same examination.

The FDA states that a positive Cologuard or Cologuard Plus result should be followed by colonoscopy.

What Is Cologuard?

Cologuard is a multitarget stool DNA test used to screen for colorectal cancer and certain precancerous lesions.

The test analyzes a stool sample for:

• colorectal neoplasia-associated DNA markers;

• and occult blood.

The original Cologuard test received FDA approval for average-risk adults age 50 and older and was later expanded to adults age 45 and older.

A newer version, Cologuard Plus, was FDA-approved in 2024 for adults age 45 and older at average risk for colorectal cancer.

Because both names may appear in searches and medical records, it is useful to distinguish the original Cologuard test from Cologuard Plus.

What Is Cologuard Plus?

Cologuard Plus is the newer generation of the multitarget stool DNA screening test.

The FDA indication is for adults age 45 or older who are at average risk for colorectal cancer. A positive result may indicate colorectal cancer or an advanced precancerous lesion and should be followed by colonoscopy.

The FDA's clinical evaluation of Cologuard Plus included 18,911 participants in the primary effectiveness population.

In that study, Cologuard Plus detected:

• 95.3% of colorectal cancers;

• 43.3% of advanced precancerous lesions;

with specificity of 90.7% for the study's category 3–6 group.

Those numbers describe test performance in a clinical study. They should not be interpreted as a guarantee that Cologuard Plus will detect or exclude cancer in an individual person.

How Does a Colonoscopy Work?

A colonoscopy uses a flexible instrument with a camera to examine the lining of the rectum and colon.

Before the procedure, the colon must be emptied with bowel preparation.

During the examination, the clinician can:

• inspect the colon;

• identify polyps;

• remove many polyps;

• take biopsies;

• and investigate suspicious areas.

This ability to both detect and remove many polyps is one of the major differences between colonoscopy and stool-based screening.

The USPSTF describes colonoscopy as a direct-visualization screening test and notes that it can combine screening and diagnostic follow-up in the same examination.

Is Cologuard as Good as a Colonoscopy?

It depends on what you mean by "as good."

Cologuard and colonoscopy are designed differently.

Cologuard detects biological signals in stool.

Colonoscopy directly visualizes the inside of the colon.

A colonoscopy can also remove many polyps during the procedure.

Therefore, comparing the two using one sensitivity number can be misleading.

A negative Cologuard result means that the test did not detect the signals it was designed to identify.

It does not mean that a colonoscopy would necessarily find nothing.

Likewise, choosing Cologuard does not mean a person is receiving an inferior form of screening if it is an appropriate option and the person completes testing as recommended.

The most important question is whether the screening strategy is appropriate for the individual's risk and whether the person will complete the entire screening pathway.

Which Finds More Polyps: Cologuard or Colonoscopy?

Colonoscopy has an important advantage here.

Because it directly examines the colon, the clinician can identify and remove many polyps during the procedure.

Cologuard does not see or remove polyps.

Instead, it looks for molecular and blood-related signals associated with colorectal neoplasia.

This distinction is particularly important because some precancerous lesions may not produce enough detectable signals to trigger a positive stool test.

In the FDA evaluation of Cologuard Plus, sensitivity for advanced precancerous lesions was 43.3%.

That means a negative Cologuard Plus test does not rule out every precancerous lesion.

Can Cologuard Prevent Colon Cancer?

Cologuard itself does not remove polyps.

However, colorectal cancer screening can contribute to prevention by identifying abnormalities that require further evaluation.

If Cologuard is positive and the follow-up colonoscopy finds a precancerous polyp, that polyp may be removed.

The preventive benefit therefore depends on completing the screening pathway.

This is why a positive stool test should not simply be ignored.

The American Cancer Society's 2026 guideline emphasizes that positive results from non-colonoscopy screening tests should be followed by timely colonoscopy.

How Often Do You Need Cologuard?

After a negative Cologuard result, the recommended screening interval is generally every three years for appropriate average-risk adults.

Cologuard's current patient information cites the American Cancer Society recommendation of repeating screening three years after a negative result.

This differs from FIT, which is generally performed every year.

It also differs from average-risk screening colonoscopy, which is generally performed every 10 years when the examination is normal and no other risk factors or findings require a different interval.

How Often Do You Need a Colonoscopy?

For average-risk adults, colonoscopy is generally performed every 10 years as a screening test when the examination is normal and the person remains an appropriate candidate for this interval.

The USPSTF lists colonoscopy every 10 years among its recommended colorectal cancer screening strategies.

However, the 10-year interval does not apply to everyone.

A person may need a different surveillance schedule after:

• certain polyps;

• colorectal cancer;

• certain family histories;

• inflammatory bowel disease;

• or other high-risk findings.

The appropriate interval should come from the healthcare professional managing the patient's screening or surveillance.

What Happens If Cologuard Is Positive?

A positive Cologuard result does not mean you have colorectal cancer.

It means the test detected signals that require further evaluation.

The next step is generally a colonoscopy.

The FDA labeling for Cologuard and Cologuard Plus states that positive results should be followed by colonoscopy.

The colonoscopy may find:

• colorectal cancer;

• an advanced precancerous lesion;

• another type of polyp;

• a noncancerous condition;

• or no significant abnormality.

A positive Cologuard result should therefore be treated as a reason for further evaluation, not as a cancer diagnosis.

What Happens If Cologuard Is Negative?

A negative result means the test did not detect the markers it was designed to identify.

It does not guarantee that there is no colorectal cancer or precancerous lesion.

The FDA's labeling specifically warns that a negative Cologuard result does not guarantee the absence of cancer or advanced adenoma.

For an appropriate average-risk adult, a negative result generally means continuing the screening program and repeating Cologuard at the recommended interval.

If symptoms develop, however, a negative stool test should not be used as a reason to ignore those symptoms.

Does Cologuard Require Bowel Preparation?

No traditional colonoscopy-style bowel preparation is required to collect a Cologuard sample.

That is one of its biggest practical advantages.

The test is performed using a stool sample collected at home and sent to a laboratory.

Cologuard's current information says patients can collect the sample at home without the bowel preparation associated with colonoscopy.

This can make stool-based screening more acceptable to people who have avoided colonoscopy because of the preparation.

Does Cologuard Require Sedation?

No.

Cologuard is a stool-based laboratory test, so there is no procedure requiring sedation.

Colonoscopy, by contrast, commonly involves sedation or anesthesia, depending on the facility and patient's circumstances.

The USPSTF identifies the need for bowel preparation, anesthesia or sedation, and transportation as practical burdens associated with colonoscopy.

Is Cologuard Easier Than Colonoscopy?

For many people, yes.

The Cologuard process generally involves:

1. receiving the kit;

2. collecting the stool sample at home;

3. sending the sample to the laboratory;

4. receiving the result;

5. repeating screening after the recommended interval if the result is negative.

There is no colonoscopy preparation, sedation or procedure.

But there is one important condition:

If the result is positive, the screening process usually continues with a colonoscopy.

So Cologuard can reduce the number of people who initially need colonoscopy, but it does not eliminate colonoscopy from the screening pathway.

Is Colonoscopy More Convenient Because You Only Need It Every 10 Years?

For some people, yes.

Colonoscopy requires considerably more preparation for each examination.

But if a normal colonoscopy is appropriate for a 10-year interval, a person does not need to remember an annual or three-year stool test.

That creates a different type of tradeoff:

Cologuard

Less invasive now → repeat every 3 years.

Colonoscopy

More preparation and a procedure now → generally repeat every 10 years if appropriate.

Neither approach is automatically better for every patient.

Which Is More Accurate: Cologuard or Colonoscopy?

This question needs careful wording.

Colonoscopy is commonly treated as the reference examination for evaluating the colon because it directly visualizes the bowel and allows tissue removal.

Cologuard is a screening test whose performance is measured against colonoscopy and pathology in clinical studies.

For example, the FDA's evaluation of Cologuard Plus found 95.3% sensitivity for colorectal cancer and 43.3% sensitivity for advanced precancerous lesions.

The original Cologuard test had colorectal cancer sensitivity of 92.3% in its pivotal study, according to FDA materials.

These numbers should not be interpreted as a direct statement that "Cologuard is 95% as accurate as colonoscopy."

They measure different things.

Does Cologuard Miss Polyps?

Yes.

No screening test detects every colorectal abnormality.

Cologuard is particularly different from colonoscopy because it does not directly visualize the colon.

The FDA study of Cologuard Plus found 43.3% sensitivity for advanced precancerous lesions.

Therefore, a negative stool test cannot guarantee that there are no polyps.

This is one reason regular repeat screening is important.

Does Colonoscopy Miss Cancer?

Colonoscopy is highly effective, but no medical test is perfect.

Detection can be affected by factors such as:

• bowel preparation quality;

• visibility;

• anatomy;

• lesion characteristics;

• operator performance;

• and the biological behavior of a lesion.

A high-quality colonoscopy is an important screening and diagnostic tool, but it should not be described as an absolute guarantee that cancer can never develop afterward.

Which Test Is Better for Someone Afraid of Colonoscopy?

If fear of colonoscopy is causing someone to avoid colorectal cancer screening altogether, an appropriate stool-based test can be a reasonable alternative for an average-risk adult.

The ACS specifically emphasizes patient choice among recommended screening options because completing screening matters.

For example:

No screening because colonoscopy is unacceptable

is generally a worse situation than

completed evidence-based stool screening with appropriate follow-up.

But a person choosing Cologuard should understand that a positive result may still lead to colonoscopy.

Is Cologuard Appropriate for Everyone?

No.

Cologuard is intended for adults at average risk.

It is not a replacement for diagnostic colonoscopy or surveillance colonoscopy in high-risk individuals.

Cologuard's current guidance identifies situations in which it is not the appropriate screening choice, including certain people with:

• a personal history of colorectal cancer;

• adenomas or certain polyps;

• inflammatory bowel disease;

• hereditary cancer syndromes;

• or a personal or first-degree family history of colorectal cancer.

If you have any of these risk factors, ask a healthcare professional which screening or surveillance strategy is appropriate.

What If You Have Symptoms?

This is an important distinction.

Routine colorectal cancer screening is intended for people without symptoms.

If you have symptoms such as:

• rectal bleeding;

• blood in the stool;

• persistent changes in bowel habits;

• unexplained weight loss;

• unexplained anemia;

• or persistent abdominal symptoms,

you may need diagnostic evaluation rather than an at-home screening test.

A Cologuard test should not be used as a substitute for medical evaluation of concerning symptoms.

Cologuard vs Colonoscopy for People With Family History

Family history can change the screening strategy.

A person with a first-degree relative who had colorectal cancer or certain advanced polyps may need screening earlier, more frequently, or with a different test.

That means the simple question:

"Should I choose Cologuard or colonoscopy?"

may not be enough.

The first question should be:

"Am I actually average risk?"

If the answer is no, the screening plan should be individualized.

Cologuard vs Colonoscopy: Cost

Cost is another major reason people compare these tests.

But there is no single national price that applies to everyone.

The cost of colonoscopy can vary based on:

• geographic location;

• facility;

• physician fees;

• anesthesia or sedation;

• pathology;

• polyp removal;

• insurance plan;

• deductible;

• coinsurance;

• and whether the procedure is classified as preventive or diagnostic.

Cologuard costs can also vary according to insurance and eligibility.

For people with Medicare who meet the eligibility requirements, Medicare Part B covers multi-target stool DNA screening every three years, and Medicare says beneficiaries pay nothing when the provider accepts assignment. Medicare also states that it covers the follow-up colonoscopy after a positive multi-target stool DNA screening test as a screening service.

Private insurance coverage can vary, so patients should verify benefits before testing.

Is Cologuard Covered by Medicare?

Yes, for eligible beneficiaries.

Medicare Part B covers at-home multi-target stool DNA screening every three years when the beneficiary meets the applicable conditions.

Medicare's eligibility criteria include:

• age 45 through 85;

• no symptoms of colorectal disease;

• average colorectal cancer risk;

• and no qualifying personal or family history that would place the person outside the average-risk category.

Medicare also states that if the screening test is positive, the follow-up colonoscopy is covered as a screening service.

Coverage rules for people with other insurance should be confirmed with the specific plan.

Does a Positive Cologuard Make Colonoscopy More Expensive?

Potentially, depending on the insurance plan and how the follow-up procedure is classified.

This is an important issue to ask about before choosing any non-colonoscopy screening test.

Ask your insurer:

"If my Cologuard test is positive, how will the follow-up colonoscopy be covered?"

The answer can depend on the insurance plan and applicable federal or state rules.

For Medicare, current Medicare guidance specifically says the follow-up colonoscopy after a positive multi-target stool DNA screening test is covered as a screening service when the applicable requirements are met.

Cologuard vs Colonoscopy: Which Is Better for Older Adults?

Age alone does not determine the answer.

The ACS 2026 guideline recommends routine screening through age 75 for average-risk adults who have a life expectancy greater than 10 years.

For adults ages 76 through 85, screening should be individualized based on factors such as health, life expectancy and previous screening history.

People older than 85 generally should not continue routine screening.

For an older adult, the potential benefits and burdens of colonoscopy and stool testing should therefore be discussed with a healthcare professional.

What About Cologuard vs Colonoscopy After Age 75?

There is no universal answer.

A person who has never been screened may potentially benefit from screening even at an older age, depending on health and life expectancy.

Another person with substantial medical problems and limited life expectancy may receive little benefit from continued screening.

The decision should be individualized rather than based only on a person's birthday.

Can You Use Cologuard Instead of Colonoscopy Forever?

Only if the person remains an appropriate average-risk candidate and continues to receive negative results and complete screening at the recommended interval.

Cologuard is not a one-time test.

A person choosing Cologuard generally needs to repeat screening every three years after a negative result.

If a future test is positive, colonoscopy is generally required.

And if a person's risk status changes, the screening strategy may need to change.

What If You Start With Cologuard and Later Want a Colonoscopy?

That is possible.

A person can discuss changing screening strategies with their healthcare professional.

For example, someone may prefer Cologuard initially because they want an at-home test, then later choose colonoscopy because of age, changing risk factors, personal preference or another medical reason.

The important point is to remain current with an appropriate screening strategy.

Cologuard vs Colonoscopy: Pros and Cons

Cologuard advantages

• At-home collection.

• No traditional bowel preparation.

• No sedation.

• No procedure.

• Noninvasive.

• Screening can be repeated every three years after a negative result.

• May be more acceptable to people who would otherwise avoid screening.

Cologuard disadvantages

• Does not directly examine the colon.

• Does not remove polyps.

• Can produce false-positive results.

• Can produce false-negative results.

• Requires repeat testing every three years.

• A positive result generally requires colonoscopy.

Colonoscopy advantages

• Directly examines the colon and rectum.

• Can identify many polyps.

• Can remove many polyps during the same procedure.

• Can obtain biopsies.

• Generally requires screening only every 10 years for average-risk adults with an appropriate normal examination.

• Can serve as follow-up after an abnormal non-colonoscopy screening test.

Colonoscopy disadvantages

• Requires bowel preparation.

• Requires a medical procedure.

• Sedation or anesthesia is commonly used.

• Transportation home may be necessary after sedation.

• Has procedural risks, including bleeding and perforation.

• Can be more burdensome than an at-home stool test.

The USPSTF specifically notes the tradeoffs between stool-based testing and colonoscopy, including repeat testing, follow-up colonoscopy, bowel preparation, sedation and procedure-related harms.

Cologuard vs Colonoscopy: Which Should You Choose?

A practical decision can start with five questions.

1. Are you average risk?

If you have previous colorectal cancer, certain polyps, inflammatory bowel disease, hereditary syndromes or significant family history, ask about a personalized screening strategy.

2. Will you actually complete colonoscopy?

If the answer is yes, colonoscopy may be an attractive option because it directly examines the colon and can remove many polyps.

3. Are you likely to avoid screening because of colonoscopy preparation?

If so, an appropriate stool-based test may be preferable to avoiding screening altogether.

4. Are you willing to have a colonoscopy if Cologuard is positive?

This is essential.

Choosing Cologuard does not mean that colonoscopy will never be necessary.

5. What does your insurance cover?

Ask about both the initial screening test and any follow-up procedure.

Cologuard vs Colonoscopy: Decision Guide

This is a decision framework, not an individualized medical recommendation.

Cologuard vs Colonoscopy: What About FIT?

FIT is another important alternative.

It is generally performed every year and is also completed at home.

Compared with Cologuard, FIT:

• is usually simpler;

• requires less frequent collection per test;

• is repeated annually;

• and generally costs less as a laboratory screening method.

Cologuard uses both DNA markers and occult blood detection, while FIT primarily detects blood in stool.

The USPSTF lists annual FIT and stool DNA-FIT as recommended screening strategies for average-risk adults.

So the real choice for many adults is not simply:

Cologuard vs colonoscopy

but:

Which evidence-based screening strategy am I most likely to complete?

Does a Negative Cologuard Mean You Can Skip Screening for 10 Years?

No.

This is one of the most important differences.

A negative Cologuard does not create a 10-year screening interval.

For an appropriate average-risk adult, Cologuard is generally repeated every three years after a negative result.

The 10-year interval is associated with average-risk screening colonoscopy when the examination is appropriate and normal.

Does a Negative Colonoscopy Mean You Never Need Screening Again?

No.

A normal screening colonoscopy does not mean colorectal cancer screening is permanently finished.

For average-risk adults, the typical interval after an appropriate normal screening colonoscopy is 10 years.

Screening may stop later in life depending on age, health, life expectancy and previous screening history.

Which Is More Likely to Require a Second Procedure?

Cologuard.

The reason is built into the screening strategy.

If Cologuard is positive, a colonoscopy is generally required.

The USPSTF notes that abnormal stool-based screening tests require follow-up colonoscopy for the benefits of screening to be achieved.

A screening colonoscopy, by contrast, is already the direct examination.

If a polyp is found, it can often be removed during the same procedure.

What Is the Biggest Mistake People Make With Cologuard?

The biggest mistake is treating a stool test as a substitute for all future colonoscopy.

Cologuard is an alternative initial screening strategy for appropriate average-risk adults.

It is not a replacement for colonoscopy when:

• the result is positive;

• symptoms require diagnostic evaluation;

• high-risk surveillance is indicated;

• or a healthcare professional determines colonoscopy is necessary.

The FDA explicitly states that Cologuard is not a replacement for diagnostic colonoscopy or surveillance colonoscopy in high-risk individuals.

Frequently Asked Questions

Is Cologuard better than colonoscopy?

Not universally.

Cologuard is less invasive and easier to complete at home, while colonoscopy directly examines the colon and can remove many polyps.

The better choice depends on risk, preference and the likelihood that the person will complete screening.

Is Cologuard as accurate as colonoscopy?

They are different types of tests and should not be compared using one simple accuracy percentage.

Colonoscopy directly visualizes the colon.

Cologuard detects molecular and blood-related signals in stool.

How often do you need Cologuard?

Generally every three years after a negative result for appropriate average-risk adults.

How often do you need a colonoscopy?

Generally every 10 years for average-risk screening when the colonoscopy is normal and a 10-year interval is appropriate.

What happens if Cologuard is positive?

A positive result generally requires follow-up colonoscopy. It does not by itself diagnose cancer.

Can Cologuard detect polyps?

It can detect signals associated with some precancerous lesions, but it does not directly see or remove polyps.

Can I use Cologuard if I have a family history of colon cancer?

Not necessarily. A personal or first-degree family history can change your risk category and screening strategy. Discuss this with a healthcare professional.

Can I use Cologuard if I have symptoms?

Routine Cologuard screening is not a substitute for diagnostic evaluation of concerning symptoms.

Does Medicare cover Cologuard?

Medicare Part B covers eligible multi-target stool DNA screening every three years and also covers the follow-up colonoscopy after a positive result under its current screening benefit rules.

Is Cologuard completely risk-free?

The stool collection itself is noninvasive, but false-positive and false-negative results can occur. A false-positive result can lead to a colonoscopy and its associated procedural risks.

Cologuard vs Colonoscopy in 2026: Quick Comparison

The Bottom Line

For average-risk adults in the United States, both Cologuard and colonoscopy can be appropriate colorectal cancer screening options, but they serve different purposes.

Cologuard is an at-home stool-based screening test. It avoids bowel preparation and sedation and can be repeated every three years after a negative result.

Colonoscopy directly examines the colon, allows doctors to remove many polyps during the procedure and generally requires screening every 10 years when an average-risk examination is normal and the 10-year interval is appropriate.

The most important difference is what happens after an abnormal result:

Positive Cologuard → colonoscopy.

A person who chooses Cologuard should therefore be comfortable with the possibility of having a colonoscopy later.

For someone who strongly prefers an at-home test and is at average risk, Cologuard may be a practical screening option.

For someone who wants direct visualization and the ability to remove many polyps during the same examination, colonoscopy may be preferable.

The best screening test is not necessarily the one that sounds most advanced.

It is the evidence-based test that fits your risk level and that you are willing to complete on schedule.

If you are age 45 or older and have not been screened, talk with your healthcare professional about whether Cologuard, colonoscopy or another recommended colorectal cancer screening strategy makes the most sense for you.

Official Medical Sources

This article was fact-checked against:

• U.S. Food and Drug Administration (FDA)

• American Cancer Society (ACS)

• U.S. Preventive Services Task Force (USPSTF)

• Medicare.gov

• Cologuard / Exact Sciences FDA-cleared labeling and patient information

Key sources reviewed:

• FDA approval and labeling for Cologuard.

• FDA approval and clinical performance information for Cologuard Plus.

• ACS 2026 colorectal cancer screening guidance.

• USPSTF colorectal cancer screening recommendations.

• Medicare coverage for multi-target stool DNA screening.

Last reviewed for source accuracy: October 2026.

Medical disclaimer: This article is for general educational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Screening recommendations and insurance coverage can change. People with symptoms or higher-than-average colorectal cancer risk may need individualized evaluation.